UNSPSC 51173232: Mineral oil/phenolphthalein

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173232 Mineral oil/phenolphthalein is a Commodity code that captures pharmaceutical and chemical products used in state and local government operations, though recent solicitations show limited direct alignment with the code's nominal scope. The three most recent opportunities tagged under this code involve offender drug testing services (Collin County, Texas), a therapeutic pharmacy initiative direct-to-manufacturer prescription program (Texas Health and Human Services Commission), and a multi-source generic pharmaceuticals and OTC product supply contract (Minnesota Multistate Cooperative Purchasing Alliance covering multiple states including Oregon). The issuing bodies span county supervision and corrections departments, state health and human services agencies, and multi-state cooperative purchasing organizations. The actual procurement activity centers on pharmaceutical supply chains, drug testing laboratory services, and pharmacy benefit administration rather than the specific mineral oil/phenolphthalein chemical or pharmaceutical ingredient. State and local governments buying under this code appear to be sourcing finished pharmaceuticals, testing services, and pharmacy network services rather than raw chemical inputs.

Recent activity is geographically concentrated in Texas and Minnesota, with the MMCAP cooperative extending to Oregon. The Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services with a due date of July 23, 2026, seeking laboratory certification from SAMHSA, Texas DPS, or CAP to support approximately 25,031 annual tests under a two-year contract with estimated value of $600,000. The Minnesota Department of Administration's Office of State Procurement issued an RFP for generic multi-source pharmaceuticals and OTC products through MMCAP on January 20, 2026, with proposals due March 26, 2026, requiring vendors to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities, signaling exploratory procurement activity ahead of a formal RFP. The code shows modest recent activity with a mismatch between its nominal chemical identity and the pharmaceutical services and finished-product procurement dominating current solicitations.